Catholic University of Sacred heart
Rome, Italy
NCT Number: NCT01627808
The purpose of this study is to analyze hemodynamic changes, in patients undergoing liver resection, through the Vigileo/FloTrac system.
Looking for future studies?
Notify Me30 year–70 year
All sexes
Observational
Rome, Italy
To reduce bleeding, hepatectomies are performed with low central pressure (CVP) combined with extrahepatic control flow.
This management can lead hemodynamic instability and reduction in oxygen delivery so an advanced monitoring should be used.
This study analyzes hemodynamic changes, in patients undergoing liver resection, through the Vigileo/FloTrac system.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: at time of surgery
Evaluation of changes in Stroke Volume Variation from Vigileo/FloTrac system during liver resection.
Time frame: at the end of surgery
Evaluation of changes in Stroke Volume Variation at the end of liver resection, during fluid optimization.
Catholic University of the Sacred Heart
Other
Study on Fluid Optimization in Liver Surgery Trough Vigileo/FloTac System Associated to Traditional Monitoring.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03133286
Adnexal Diseases, Anus Diseases
Compton, California, United States
View Trial DetailsNCT05907772
Cancer of Liver, Digestive System Diseases
Hangzhou, Zhejiang, China
View Trial DetailsNCT05030090
Cancer of Colon, Cancer of Liver
Taipei, Taiwan
View Trial DetailsNCT05643833
Cancer of Liver, Digestive System Diseases
Hangzhou, Zhejiang, China
View Trial Details